Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Leprosy is an infectious disease of slow evolution, manifested primarily by signs and symptoms dermatoneurological with skin lesions and peripheral nerve, especially in the eyes, hands and feet. The prevention of disability is essential for the control of complications. Objective: To evaluate the physical and functional status of hands, feet and eyes, for the appearance and evolution of sensory and motor deficiencies and classification of disability (WHO) of a group of leprosy patients to compare and monitor the result treatment on the progression of neuropathy and recurrence of reactions. Methodology: We performed initial physical therapy evaluation and final, after 12 months. We conducted a clinical trial of a series of 26 cases evaluated with newly diagnosed leprosy, treated by standard medication. There were used methods of qualitative and quantitative. An illustrated manual of guidelines was especially developed for this study.
| Condition | Intervention | Phase |
|---|---|---|
|
Leprosy Disability Evaluation Quality of Life |
Other: exercise and orientation |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Proposal Evaluation and Intervention Through Prevention of Disability in Leprosy Patients |
- classification of disability for Leprosy(WHO) [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
- classification of disability for Leprosy(WHO), grip strength and threshold sensibility [ Time Frame: after 1 year ] [ Designated as safety issue: Yes ]
| Enrollment: | 55 |
| Study Start Date: | January 2007 |
| Study Completion Date: | August 2009 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: leprosy disability
intervention of a series of cases with leprosy that made treatment in a Clinical Hospital
|
Other: exercise and orientation
guidances for prevention of disability in leprosy with focus on hands, eyes and feet.
Other Names:
|
Detailed Description:
assessment methods of qualitative and quantitative: inspection of eyes, hands and foot, manual motor function, grip and pinch dynamometry,threshold test, SF 36 quality of life questionnaire.
Intervention: illustrated guidelines, exercises, orthoses, orientation Goals: disability prevention
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patients in this project were diagnosed and referred by the dermatology to do the physical-functional evaluation and physiotherapy. We selected patients aged 18 years and both sexes, even with comorbidities, since diagnosed and treated. In accepting to participate in the research, signed a consent form
Exclusion Criteria:
- Those patients who refused to sign the consent form and those who did not attend the evaluations
Contacts and Locations| Brazil | |
| School of Medicine, University of Sao Paulo | |
| Ribeirao Preto, SP, Brazil, 14049900 | |
| Principal Investigator: | Marisa CR Fonseca, PhD | University of Sao Paulo |
More Information
Additional Information:
Publications:
| Responsible Party: | Marisa de Cássia Registro Fonseca, School of Medicine, University of Sao Paulo |
| ClinicalTrials.gov Identifier: | NCT01006759 History of Changes |
| Other Study ID Numbers: | FMRPUSP, HCRP n°14553/2005 |
| Study First Received: | November 2, 2009 |
| Last Updated: | November 2, 2009 |
| Health Authority: | Brazil: Ministry of Health |
Keywords provided by University of Sao Paulo:
|
Leprosy Disability Evaluation Quality of Life Sensation |
Additional relevant MeSH terms:
|
Leprosy Mycobacterium Infections Actinomycetales Infections Gram-Positive Bacterial Infections Bacterial Infections |
ClinicalTrials.gov processed this record on May 21, 2013